BOSTON - NMT Medical, Inc. has received Pre-Market Approval from the US Food and Drug Administration for the sale of its STARFlex cardiac septal repair implant in the United States for patients with ventricular septal defects (VSD), an opening between the right and left ventricle in the lower chambers of the heart.